Metformin therapy and circulating NT-proBNP levels: the CAMERA trial by Preiss, D, Welsh, P, Sattar, N

Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future. by Rankin, N, Preiss, D, Welsh, P, Sattar, N

Associations of targeted circulating microRNAs with insulin resistance in the CAMERA (Carotid Atherosclerosis: MEtformin for insulin ResistAnce) trial by Alramah, T, Preiss, D, Sattar, N, Logue, J, Welsh, P

Cardiac troponin T and troponin I in the general population: comparing and contrasting their genetic determinants and associations with outcomes by Welsh, P, Preiss, D, Hayward, C, Woodward, M, al, E

Does interleukin-18 or tumour necrosis factor-α have an independent association with the risk of coronary heart disease? Results from a prospective study in New Zealand by Welsh, P, Woodward, M, Rumley, A, MacMahon, S, Lowe, G

Putative miRNA biomarkers of insulin resistance and the effect of metformin: data from the CAMERA trial by ALRamah, T, Pinel, K, Preiss, D, Sattar, N, Logue, J, Welsh, P

Do inflammatory biomarkers add to the discrimination of cardiovascular disease after allowing for social deprivation? Results from a 10-year cohort study in Glasgow, Scotland. by Woodward, M, Welsh, P, Rumley, A, Tunstall-Pedoe, H, Lowe, G

Associations of proinflammatory cytokines with the risk of recurrent stroke. by Welsh, P, Lowe, G, Chalmers, J, Campbell, D, Rumley, A, Neal, B, MacMahon, S, Woodward, M

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): A randomised controlled trial by Preiss, D, Lloyd, S, Ford, I, McMurray, J, Holman, R, Welsh, P, Fisher, M, Packard, C, Sattar, N

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. by Preiss, D, Lloyd, S, Ford, I, McMurray, J, Holman, R, Welsh, P, Fisher, M, Packard, C, Sattar, N

Effect of metformin therapy on circulating amino acids in a randomized trial: the CAMERA study: Metabolism by Preiss, D, Rankin, N, Welsh, P, Holman, R, Kangas, A, Soininen, P, Würtz, P, Ala-Korpela, M, Sattar, N

Personalized medication response prediction for attention-deficit hyperactivity disorder: Learning in the model space vs. learning in the data space by Wong, H, Tiffin, P, Chappell, M, Nichols, T, Welsh, P, Doyle, O, Lopez-Kolkovska, B, Inglis, S, Coghill, D, Shen, Y, Tiño, P

Body mass index and risk of non-alcoholic fatty liver disease: Two electronic health record prospective studies. by Katrina Loomis, A, Kabadi, S, Preiss, D, Hyde, C, Bonato, V, Louis, M, Desai, J, Gill, J, Welsh, P, Waterworth, D, Sattar, N

Prediction of cardiovascular disease risk by cardiac biomarkers in 2 United Kingdom cohort studies by Welsh, P, Hart, C, Papacosta, O, Preiss, D, McConnachie, A, Murray, H, Ramsay, S, Upton, M, Watt, G, Whincup, P, Wannamethee, G, Sattar, N

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial by Welsh, P, Rankin, N, Li, Q, Mark, P, Würtz, P, Ala-Korpela, M, Marre, M, Poulter, N, Hamet, P, Chalmers, J, Woodward, M, Sattar, N

Evaluating an intervention to increase cereal fiber intake in children: A randomized controlled feasibility trial by Donin, AS, Nightingale, CM, Perkin, MR, Ussher, M, Jebb, SA, Landberg, R, Welsh, P, Sattar, N, Adab, P, Owen, CG, Rudnicka, AR, Cook, DG, Whincup, PH

The sustained influence of metformin therapy on circulating GLP-1 levels in individuals with and without type 2 diabetes by Preiss, D, Dawed, A, Welsh, P, Heggie, A, Jones, A, Dekker, J, Koivula, R, Hansen, T, DIRECT consortium, Stewart, C, Holman, R, Franks, P, Walker, M, Pearson, E, Sattar, N

Cardiac stress and inflammatory markers as predictors of heart failure in patients with type 2 diabetes: the ADVANCE trial by Ohkuma, T, Jun, M, Woodward, M, Zoungas, S, Cooper, M, Grobbee, D, Hamet, P, Mancia, G, Williams, B, Welsh, P, Sattar, N, Shaw, J, Rahimi, K, Chalmers, J, ADVANCE Collaborative Group

Comparison between high-sensitivity cardiac troponin T and cardiac troponin I in a large general population cohort by Welsh, P, Preiss, D, Shah, A, McAllister, D, Briggs, A, Boachie, C, McConnachie, A, Hayward, C, Padmanabhan, S, Welsh, C, Woodward, M, Campbell, A, Porteous, D, Mills, N, Sattar, N

Comparison between high-sensitivity cardiac troponin T and cardiac troponin I in a large general population cohort by Welsh, P, Preiss, D, Shah, A, McAllister, D, Briggs, A, Boachie, C, McConnachie, A, Hayward, C, Padmanabhan, S, Welsh, C, Woodward, M, Campbell, A, Porteous, D, Mills, N, Sattar, N